Chemomab Therapeutics Ltd. - American Depositary Shares (CMMB) SEC filings
CMMB SEC filings moved a median of -0.84% by the close. CMMB SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CMMB overview →
45 measured CMMB SEC filing events.
Where these CMMB SEC filings landedvs 45 measured CMMB SEC filing reactions
| Middle 50% of CMMB SEC filing reactions | -4.86% to +3.60% |
|---|---|
| Median reaction (to close) | -0.84% |
| Measured reactions | 45 |
Point-in-time · zero look-ahead
Half of the 45 CMMB SEC filing events with a measured close landed between -4.86% and +3.60%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form DEFA14A Chemomab Therapeutics | SEC filing · Form DEFA14A | +6.77% | +1.50% | |
| Form 6-K Chemomab Therapeutics For: Nov 03 | SEC filing · Form 6-K | -4.51% | -11.28% | |
| Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective | Press release | -1.23% | -3.28% | |
| Form DEFM14A Chemomab Therapeutics | SEC filing · Form DEFM14A | -1.23% | -3.28% | |
| Form 6-K Chemomab Therapeutics For: Oct 19 | SEC filing · Form 6-K | +3.36% | -0.84% | |
| Form 6-K Chemomab Therapeutics For: Sep 30 | SEC filing · Form 6-K | +2.40% | +4.00% | |
| Form 6-K Chemomab Therapeutics For: Jun 30 | SEC filing · Form 6-K | -3.57% | +6.63% | |
| Form 6-K Chemomab Therapeutics For: Jul 08 | SEC filing · Form 6-K | -8.66% | -14.72% | |
| Form 6-K Chemomab Therapeutics For: Jun 02 | SEC filing · Form 6-K | +3.45% | -1.15% | |
| Form 6-K Chemomab Therapeutics For: May 14 | SEC filing · Form 6-K | +3.15% | -0.58% | |
| Form 6-K Chemomab Therapeutics For: May 06 | SEC filing · Form 6-K | -0.27% | -5.43% | |
| Form 6-K Chemomab Therapeutics For: Apr 28 | SEC filing · Form 6-K | -1.39% | -5.81% | |
| Form 20-F Chemomab Therapeutics For: Dec 31 | SEC filing · Form 20-F | +3.02% | -5.99% | |
| Form 6-K Chemomab Therapeutics For: Mar 20 | SEC filing · Form 6-K | -0.28% | -6.14% | |
| Form 6-K Chemomab Therapeutics For: Mar 19 | SEC filing · Form 6-K | +0.25% | -3.50% | |
| Form 6-K Chemomab Therapeutics For: Nov 21 | SEC filing · Form 6-K | -2.21% | +1.61% | |
| Form 6-K Chemomab Therapeutics For: Aug 22 | SEC filing · Form 6-K | -1.01% | -2.15% | |
| Form 6-K Chemomab Therapeutics For: Jun 30 | SEC filing · Form 6-K | -2.45% | -4.86% | |
| Form 6-K Chemomab Therapeutics For: Jul 25 | SEC filing · Form 6-K | -5.74% | -6.84% | |
| Form 6-K Chemomab Therapeutics For: Jul 01 | SEC filing · Form 6-K | +0.00% | -0.86% | |
| Form 6-K Chemomab Therapeutics For: May 27 | SEC filing · Form 6-K | +2.14% | -2.14% | |
| Form 6-K Chemomab Therapeutics For: May 15 | SEC filing · Form 6-K | -1.60% | +8.40% | |
| Form 6-K Chemomab Therapeutics For: Apr 15 | SEC filing · Form 6-K | +0.00% | +0.83% | |
| Form 20-F Chemomab Therapeutics For: Dec 31 | SEC filing · Form 20-F | +9.18% | +4.08% | |
| Form 6-K Chemomab Therapeutics For: Mar 27 | SEC filing · Form 6-K | -2.22% | -18.52% | |
| Form 6-K Chemomab Therapeutics For: Mar 20 | SEC filing · Form 6-K | +0.00% | +0.79% | |
| Form 6-K Chemomab Therapeutics For: Mar 03 | SEC filing · Form 6-K | +2.45% | -7.36% | |
| Form 6-K Chemomab Therapeutics For: Feb 19 | SEC filing · Form 6-K | -4.57% | -3.55% | |
| Form EFFECT Chemomab Therapeutics | SEC filing · Form EFFECT | +1.18% | +0.00% | |
| Form POS AM Chemomab Therapeutics | SEC filing · Form POS | +0.56% | -2.26% | |
| Form 6-K Chemomab Therapeutics For: Nov 18 | SEC filing · Form 6-K | +0.66% | +0.62% | |
| Form 6-K Chemomab Therapeutics For: Nov 14 | SEC filing · Form 6-K | +2.02% | +0.58% | |
| Form 6-K Chemomab Therapeutics For: Oct 11 | SEC filing · Form 6-K | -0.01% | +5.26% | |
| Form EFFECT Chemomab Therapeutics | SEC filing · Form EFFECT | +1.50% | +6.50% | |
| Form F-3 Chemomab Therapeutics | SEC filing · Form F-3 | +2.08% | +9.72% | |
| Form 6-K Chemomab Therapeutics For: Jun 30 | SEC filing · Form 6-K | +0.83% | +0.83% | |
| Form D Chemomab Therapeutics | SEC filing · Form D | +0.00% | -1.42% | |
| Form 6-K Chemomab Therapeutics For: Jul 25 | SEC filing · Form 6-K | +6.48% | +10.19% | |
| Form 6-K Chemomab Therapeutics For: Jun 12 | SEC filing · Form 6-K | — | +3.60% | |
| Form 6-K Chemomab Therapeutics For: May 09 | SEC filing · Form 6-K | +0.00% | +10.20% | |
| Form 6-K Chemomab Therapeutics For: May 08 | SEC filing · Form 6-K | -3.17% | -19.44% | |
| Form 6-K Chemomab Therapeutics For: May 03 | SEC filing · Form 6-K | +5.49% | +4.00% | |
| Form 20-F Chemomab Therapeutics For: Dec 31 | SEC filing · Form 20-F | -1.17% | +1.17% | |
| Form 6-K Chemomab Therapeutics For: Mar 07 | SEC filing · Form 6-K | +0.00% | +12.20% | |
| Form 6-K Chemomab Therapeutics For: Jan 03 | SEC filing · Form 6-K | -2.59% | -7.81% |
Keep exploring
More CMMB: earnings → · analyst actions → · CMMB overview →